Xeris Biopharma Reports Third Quarter 2021 Financial Results and Other Highlights
Go back to Xeris Biopharma Reports Third Quarter 2021 Financial Results and Other Highlights| (NASDAQ: XERS) | Delayed: 8.43 +0.44 (5.51%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.99 | 52 Week High | $ | |||
| Open | $8.00 | 52 Week Low | $ | |||
| Day High | $8.43 | P/E | N/A | |||
| Day Low | $7.96 | EPS | $ | |||
| Volume | 966,836 | |||||

